George A. Joulwan, Director at Emergent BioSolutions Inc. (EBS), sold 4,700 shares at $44.12 ($207K) on 2016-06-06, disclosed to the SEC on 2016-06-07.
Open-market sale of $207k EBS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EBS | SELL | 2018-11-08 | $556K | — | Filing → |
| EBS | SELL | 2018-06-12 | $264K | — | Filing → |
| EBS | SELL | 2017-11-09 | $1.2M | — | Filing → |